Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
Infectious Diseases and Therapy|June 17, 2023
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV PatientsNancy Reau, Wei-Han Cheng, Qiujun Shao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2013
Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infantsCalvin Q Pan, Huai-Bin Zou, Yu Chen, et al.
Digestive Diseases and Sciences|March 7, 2015
Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?Shreya Sengupta, Kristen Wroblewski, Andrew Aronsohn, et al.
Journal of the Pediatric Infectious Diseases Society|January 19, 2026
Cost-effectiveness of One-Time Universal Childhood Hepatitis C Screening in the United StatesJessica Frankeberger, Melissa Choz, Tatyana Kushner, et al.
Gastroenterology & Hepatology|March 15, 2017
Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on DialysisJenny Sauk, Donald M Jensen, Smruti R Mohanty, et al.
Journal of Medical Virology|May 16, 2020
The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancyLi-Xin Xiao, Yi-Ru Chen, Ping Huang, et al.
The American Journal of Gastroenterology|November 11, 2010
Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis CNancy Reau, Rohit Satoskar, Helen Te, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2018
Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Pharmacoeconomics|May 28, 2025
Health Care Resource Utilization and Costs Associated with US Medicaid Sobriety Restrictions on Direct-Acting Antivirals for Hepatitis C Virus: A Retrospective Claims Database AnalysisMichelle T Martin, Krithika Rajagopalan, Dilip Makhija, et al.
Hepatology International|July 24, 2015
Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis BBingliang Lin, Calvin Q Pan, Dongying Xie, et al.
Pageof 18